ARCHIVES

FEBT, For Pain Control, Shows Positive Results In Phase III

This article is from The Cancer Letter archive.

Vol. 29 No. 5 | May 26, 2006

Download PDF Visit The Full Archive

Related Articles

Commercial Labs Open Drive To Get More NIH Business, Including Grants

April 26, 1974

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

February 23, 2007

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991

Congress Passes Unprecedented 15% Increase For NIH On Last Day Of Session

October 23, 1998

New Atlas Showing nonwhite Mortality Rates Available

January 7, 1977

Report Urges Better Working Conditions For Postdocs.

October 6, 2000